September 2020

With an estimated of 100 million new patients diagnosed worldwide by 2050, the importance of treating Alzheimer’s disease remains a priority for ORPEA Group.  

Download our press release

For the third consecutive year, 9 rehabilitation clinics of the ORPEA Group in Germany, operating under the Celenus brand, have been rewarded by the magazine FOCUS-Gesundheit […]

The ORPEA Group joins the United Nations Global Compact by adhering to this international initiative which aims to promote the application of 10 universally recognized principles